Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial

Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 in the page metadata.
    Difference
    0.0%
    Check dated 2026-01-15T03:08:27.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added Locations sections for California, District of Columbia, Florida, Georgia, Missouri, New Jersey, Texas, and Virginia and updated the page revision to v3.3.3. Removed HHS Vulnerability Disclosure and the California, District of Columbia, Florida, Georgia, Missouri, New Jersey, Texas, and Virginia Locations entries from the previous revision (v3.3.2).
    Difference
    0.5%
    Check dated 2025-12-24T13:47:47.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added a note clarifying that PubMed-published articles are auto-filled from PubMed and may not be about the study; Revision: v3.3.2 updated from the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:52:32.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A site-wide government funding/operational status notice was removed from the page. This change does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:15:21.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No significant content changes detected for the Study Details page (NCT02429791); minor visual/formatting differences do not affect core information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:24:39.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    - Added a prominent operations/status notice and a link to cc.nih.gov, plus a reminder about government updates; - Updated version from v3.1.0 to v3.2.0.
    Difference
    0.9%
    Check dated 2025-10-06T06:41:24.000Z thumbnail image

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.